Cargando…

Capped RNA primer binding to influenza polymerase and implications for the mechanism of cap-binding inhibitors

Influenza polymerase uses short capped primers snatched from nascent Pol II transcripts to initiate transcription of viral mRNAs. Here we describe crystal structures of influenza A and B polymerase bound to a capped primer in a configuration consistent with transcription initiation (’priming state’)...

Descripción completa

Detalles Bibliográficos
Autores principales: Pflug, Alexander, Gaudon, Stephanie, Resa-Infante, Patricia, Lethier, Mathilde, Reich, Stefan, Schulze, Wiebke M, Cusack, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778463/
https://www.ncbi.nlm.nih.gov/pubmed/29202182
http://dx.doi.org/10.1093/nar/gkx1210
_version_ 1783294356325662720
author Pflug, Alexander
Gaudon, Stephanie
Resa-Infante, Patricia
Lethier, Mathilde
Reich, Stefan
Schulze, Wiebke M
Cusack, Stephen
author_facet Pflug, Alexander
Gaudon, Stephanie
Resa-Infante, Patricia
Lethier, Mathilde
Reich, Stefan
Schulze, Wiebke M
Cusack, Stephen
author_sort Pflug, Alexander
collection PubMed
description Influenza polymerase uses short capped primers snatched from nascent Pol II transcripts to initiate transcription of viral mRNAs. Here we describe crystal structures of influenza A and B polymerase bound to a capped primer in a configuration consistent with transcription initiation (’priming state’) and show by functional assays that conserved residues from both the PB2 midlink and cap-binding domains are important for positioning the capped RNA. In particular, mutation of PB2 Arg264, which interacts with the triphosphate linkage in the cap, significantly and specifically decreases cap-dependent transcription. We also compare the configuration of the midlink and cap-binding domains in the priming state with their very different relative arrangement (called the ‘apo’ state) in structures where the potent cap-binding inhibitor VX-787, or a close analogue, is bound. In the ‘apo’ state the inhibitor makes additional interactions to the midlink domain that increases its affinity beyond that to the cap-binding domain alone. The comparison suggests that the mechanism of resistance of certain mutations that allow virus to escape from VX-787, notably PB2 N510T, can only be rationalized if VX-787 has a dual mode of action, direct inhibition of capped RNA binding as well as stabilization of the transcriptionally inactive ‘apo’ state.
format Online
Article
Text
id pubmed-5778463
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-57784632018-01-30 Capped RNA primer binding to influenza polymerase and implications for the mechanism of cap-binding inhibitors Pflug, Alexander Gaudon, Stephanie Resa-Infante, Patricia Lethier, Mathilde Reich, Stefan Schulze, Wiebke M Cusack, Stephen Nucleic Acids Res Structural Biology Influenza polymerase uses short capped primers snatched from nascent Pol II transcripts to initiate transcription of viral mRNAs. Here we describe crystal structures of influenza A and B polymerase bound to a capped primer in a configuration consistent with transcription initiation (’priming state’) and show by functional assays that conserved residues from both the PB2 midlink and cap-binding domains are important for positioning the capped RNA. In particular, mutation of PB2 Arg264, which interacts with the triphosphate linkage in the cap, significantly and specifically decreases cap-dependent transcription. We also compare the configuration of the midlink and cap-binding domains in the priming state with their very different relative arrangement (called the ‘apo’ state) in structures where the potent cap-binding inhibitor VX-787, or a close analogue, is bound. In the ‘apo’ state the inhibitor makes additional interactions to the midlink domain that increases its affinity beyond that to the cap-binding domain alone. The comparison suggests that the mechanism of resistance of certain mutations that allow virus to escape from VX-787, notably PB2 N510T, can only be rationalized if VX-787 has a dual mode of action, direct inhibition of capped RNA binding as well as stabilization of the transcriptionally inactive ‘apo’ state. Oxford University Press 2018-01-25 2017-11-30 /pmc/articles/PMC5778463/ /pubmed/29202182 http://dx.doi.org/10.1093/nar/gkx1210 Text en © The Author(s) 2017. Published by Oxford University Press on behalf of Nucleic Acids Research. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Structural Biology
Pflug, Alexander
Gaudon, Stephanie
Resa-Infante, Patricia
Lethier, Mathilde
Reich, Stefan
Schulze, Wiebke M
Cusack, Stephen
Capped RNA primer binding to influenza polymerase and implications for the mechanism of cap-binding inhibitors
title Capped RNA primer binding to influenza polymerase and implications for the mechanism of cap-binding inhibitors
title_full Capped RNA primer binding to influenza polymerase and implications for the mechanism of cap-binding inhibitors
title_fullStr Capped RNA primer binding to influenza polymerase and implications for the mechanism of cap-binding inhibitors
title_full_unstemmed Capped RNA primer binding to influenza polymerase and implications for the mechanism of cap-binding inhibitors
title_short Capped RNA primer binding to influenza polymerase and implications for the mechanism of cap-binding inhibitors
title_sort capped rna primer binding to influenza polymerase and implications for the mechanism of cap-binding inhibitors
topic Structural Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778463/
https://www.ncbi.nlm.nih.gov/pubmed/29202182
http://dx.doi.org/10.1093/nar/gkx1210
work_keys_str_mv AT pflugalexander cappedrnaprimerbindingtoinfluenzapolymeraseandimplicationsforthemechanismofcapbindinginhibitors
AT gaudonstephanie cappedrnaprimerbindingtoinfluenzapolymeraseandimplicationsforthemechanismofcapbindinginhibitors
AT resainfantepatricia cappedrnaprimerbindingtoinfluenzapolymeraseandimplicationsforthemechanismofcapbindinginhibitors
AT lethiermathilde cappedrnaprimerbindingtoinfluenzapolymeraseandimplicationsforthemechanismofcapbindinginhibitors
AT reichstefan cappedrnaprimerbindingtoinfluenzapolymeraseandimplicationsforthemechanismofcapbindinginhibitors
AT schulzewiebkem cappedrnaprimerbindingtoinfluenzapolymeraseandimplicationsforthemechanismofcapbindinginhibitors
AT cusackstephen cappedrnaprimerbindingtoinfluenzapolymeraseandimplicationsforthemechanismofcapbindinginhibitors